UC San Diego Team Receives $5.8 Million to Develop Immunotherapy for Ovarian, Other Cancer Patients

UC San Diego Team Receives $5.8 Million to Develop Immunotherapy for Ovarian, Other Cancer Patients
Researchers at the University of California San Diego School of Medicine have received a $5.8 million state grant to develop an immunotherapy against hard-to-kill cancer stem cells. The team that won the 30-month grant from the California Institute for Regenerative Medicine hopes to develop a treatment that uses patients’ own cells to target cancer stem cells. The effort has

Knowledge is power when living with ovarian cancer.

Get access to the web’s leading Ovarian Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *